People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Torus Biosystems, Inc. | — | Biotechnology | Series B | $28.9M | $707.2M | 2020 |
| Pana Bio, Inc. | — | Biotechnology | Pre-Seed | $200K | $4.9M | 2021 |
David Yu Zhang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Yu Zhang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Shawn Marcell | 1 | 4 |
| Peng Yin | 1 | 3 |
| Philip Gardella | 1 | 2 |
| Omid Yu Veiseh | 1 | 1 |
| Robert Yu Britton | 1 | 1 |
| Ben Linden | 1 | 1 |
| Adam Yu Wiechhaus | 1 | 1 |
| Peng Yu Yin | 1 | 1 |
| Chenyang Victor Shi | 1 | 1 |
| Jeffrey Yu Tabor | 1 | 1 |
| Jinglin Yu Huang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.